Abivax (ABVX) Short term Debt (2021 - 2025)
Abivax (ABVX) posted quarterly Short term Debt of $1.5 million for Q4 2025, down 96.84% year-over-year from $48.0 million in Q4 2024, and down 95.59% quarter-over-quarter from $34.4 million in Q3 2025.
Abivax (ABVX) Short term Debt (2021 - 2025) Analysis & Trends
Abivax's Short term Debt history runs 5 years deep, the most recent figure standing at $1.5 million for Q4 2025.
- In Q4 2025, Short term Debt fell 96.84% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (down 96.84% YoY), while the FY2025 annual figure was $1.5 million, down 96.84% from the prior year.
- Short term Debt for Q4 2025 stood at $1.5 million, down from $34.4 million in the prior quarter.
- The five-year high for Short term Debt was $57.1 million in Q2 2025, with the low at $1.5 million in Q4 2025.
- The 5-year median for Short term Debt is $34.4 million (2025), against an average of $31.0 million.
- Peak annual rise in Short term Debt reached 2036.23% in 2025, while the deepest fall reached 96.84% in 2025.
- Abivax's Short term Debt stood at $13.0 million in 2021, then jumped by 163.78% to $34.2 million in 2022, then rose by 17.38% to $40.2 million in 2023, then advanced by 19.49% to $48.0 million in 2024, then plunged by 96.84% to $1.5 million in 2025.
- Business Quant data shows ABVX's Short term Debt at $1.5 million in Q4 2025, $34.4 million in Q3 2025, and $57.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 34.37 Mn |
| Jun 30, 2025 | 57.05 Mn |
| Mar 31, 2025 | 47.74 Mn |
| Dec 31, 2024 | 48.02 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Dec 31, 2023 | 40.18 Mn |
| Dec 31, 2022 | 34.23 Mn |
| Dec 31, 2021 | 12.98 Mn |